// App-Quantinova.ai

BS16 : The role of parasympathetic nervous system in the infarct-limiting effect of SGLT2 inhibitors

Researchers

Presenter

  • Maryna Basalay

Principal Investigators

  • Sean Davidson

  • Derek Yellon

Medical Centers

  • The Hatter Cardiovascular Institute, London

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Ischemia-reperfusion injury

Biomarkers

  • N/A

Drug/Treatment

  • MDT010

  • Ertugliflozin

  • Isoflurane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved